Betevé TV’s “Notícies Vespre” (Evening News) has broadcasted an interview with Jordi Durán, researcher with the Metabolic Engineering and Diabetes Therapy Lab at IRB Barcelona, about research into rare diseases.
This lab carries out research into Lafora disease, a genetic neurodegenerative disorder. “The aim of this work is to explain why neurons degenerate and die. What happens is that glucose, a cellular product accumulates, and this causes the neurons to progressively die, causing neurodegeneration,” says Durán.
Of note, all these discoveries being made about rare diseases can be extrapolated to more common diseases.
Link to: Betevé TV (minutes 43:30- 46:24)
About IRB Barcelona
Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).